Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays

Human Pathology

Volumn 39, Issue 2, 2008, Pages 184-193

  Patel, Kayuri U ^a   Szabo, Sara S ^a   Hernandez, Vivian S ^a   Prieto, Victor G ^b   Abruzzo, Lynne V ^b   Lazar, Alexander J F ^b   López Terrada, Dolores ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chromosomal translocation; COL1A1 PDGFB fusion gene; Dermatofibrosarcoma protuberans; Multiplex reverse transcription polymerase chain reaction

Indexed keywords

CD34 ANTIGEN; FORMALDEHYDE; PRIMER DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHROMOSOME TRANSLOCATION 17; COL1A1 PDGFB GENE; CORRELATION ANALYSIS; DERMATOFIBROSARCOMA PROTUBERANS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EXON; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRON; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RING CHROMOSOME; SEQUENCE ANALYSIS; SUPERNUMERARY CHROMOSOME;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; CHROMOSOME MAPPING; DERMATOFIBROSARCOMA; DNA, NEOPLASM; FEMALE; GENE REARRANGEMENT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, FUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS;

EID: 38149075090     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.06.009     Document Type: Article

References (35)

1. Chang C.K., Jacobs I.A., and Salti G.I. Outcomes of surgery for dermatofibrosarcoma protuberans. Eur J Surg Oncol 30 (2004) 341-345
2. Fiore M., Miceli R., Mussi C., et al. Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate. J Clin Oncol 23 (2005) 7669-7675
3. Jha P., Moosavi C., and Fanburg-Smith J.C. Giant cell fibroblastoma: an update and addition of 86 new cases from the Armed Forces Institute of Pathology, in honor of Dr. Franz M. Enzinger. Ann Diagn Pathol 11 (2007) 81-88
4. Sandberg A.A., and Bridge J.A. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Dermatofibrosarcoma protuberans and giant cell fibroblastoma. Cancer Genet Cytogenet 140 (2003) 1-12
5. Terrier-Lacombe M.J., Guillou L., Maire G., et al. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data-a study from the French Federation of Cancer Centers Sarcoma Group. Am J Surg Pathol 27 (2003) 27-39
6. Martin L., Piette F., Blanc P., et al. Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans. Br J Dermatol 153 (2005) 932-936
7. Fletcher C.D., Evans B.J., MacArtney J.C., Smith N., Wilson Jones E., and McKee P.H. Dermatofibrosarcoma protuberans: a clinicopathological and immunohistochemical study with a review of the literature. Histopathology 9 (1985) 921-938
8. West R.B., Harvell J., Linn S.C., et al. Apo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberans. Am J Surg Pathol 28 (2004) 1063-1069
9. Naeem R., Lux M.L., Huang S.F., Naber S.P., Corson J.M., and Fletcher J.A. Ring chromosomes in dermatofibrosarcoma protuberans are composed of interspersed sequences from chromosomes 17 and 22. Am J Pathol 147 (1995) 1553-1558
10. Sirvent N., Maire G., and Pedeutour F. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosomes Cancer 37 (2003) 1-19
11. Fredriksson L., Li H., and Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev 15 (2004) 197-204
12. O'Brien K.P., Seroussi E., Dal Cin P., et al. Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas. Genes Chromosomes Cancer 23 (1998) 187-193
13. Simon M.P., Pedeutour F., Sirvent N., et al. Deregulation of the platelet-derived growth factor β-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat Genet 15 (1997) 95-98
14. Sjoblom T., Shimizu A., O'Brien K.P., et al. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis. Cancer Res 61 (2001) 5778-5783
15. Rubin B.P., Schuetze S.M., Eary J.F., et al. Molecular targeting of platelet-derived growth factor β by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans. J Clin Oncol 20 (2002) 3586-3591
16. Labropoulos S.V., Fletcher J.A., Oliveira A.M., Papadopoulos S., and Razis E.D. Sustained complete remission of metastatic dermatofibrosarcoma protuberans with imatinib mesylate. Anticancer Drugs 16 (2005) 461-466
17. McArthur G.A., Demetri G.D., van Oosterom A., et al. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225. J Clin Oncol 23 (2005) 866-873
18. Wang J., Hisaoka M., Shimajiri S., Morimitsu Y., and Hashimoto H. Detection of COL1A1-PDGFB fusion transcripts in dermatofibrosarcoma protuberans by reverse transcription-polymerase chain reaction using archival formalin-fixed, paraffin-embedded tissues. Diagn Mol Pathol 8 (1999) 113-119
19. Wang J., Morimitsu Y., Okamoto S., et al. COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans. J Mol Diagn 2 (2000) 47-52
20. Zhao L., Hayes K., Khan Z., and Glassman A. Spectral karyotyping study of chromosome abnormalities in human leukemia. Cancer Genet Cytogenet 127 (2001) 143-147
21. Shmookler B.M., Enzinger F.M., and Weiss S.W. Giant cell fibroblastoma. A juvenile form of dermatofibrosarcoma protuberans. Cancer 64 (1989) 2154-2161
22. Connelly J.H., and Evans H.L. Dermatofibrosarcoma protuberans. A clinicopathologic review with emphasis on fibrosarcomatous areas. Am J Surg Pathol 16 (1992) 921-925
23. Davis D.A., and Sanchez R.L. Atrophic and plaquelike dermatofibrosarcoma protuberans. Am J Dermatopathol 20 (1998) 498-501
24. Wrotnowski U., Cooper P.H., and Shmookler B.M. Fibrosarcomatous change in dermatofibrosarcoma protuberans. Am J Surg Pathol 12 (1998) 287-293
25. Horenstein M.G., Prieto V.G., Nuckols J.D., Burchette J.L., and Shea C.R. Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans?. Am J Surg Pathol 24 (2000) 996-1003
26. Strauss R.M., Merchant W.J., Roberts P., Wright A.L., and Clark S.M. A case of childhood dermatofibrosarcoma protuberans without detected cytogenetic abnormality. Br J Dermatol 148 (2003) 1051-1055
27. Szollosi Z., Scholtz B., Egervari K., and Nemes Z. Transformed dermatofibrosarcoma protuberans: real time polymerase chain reaction detection of COL1A1-PDGFB fusion transcripts in sarcomatous areas. J Clin Pathol 60 (2007) 190-194
28. Saeki H., Tamada Y., Watanabe D., et al. Analysis of gene mutations in four cases of dermatofibrosarcoma protuberans. Clin Exp Dermatol 31 (2006) 441-444
29. Llombart B., Sanmartin O., Lopez-Guerrero J.A., et al. Analysis of the COL1A1-PDGFB fusion gene in a case of dermatofibrosarcoma protuberans with a fibrosarcoma component. Actas Dermosifiliogr 97 (2006) 337-341
30. Maire G., Pedeutour F., and Coindre J.M. COL1A1-PDGFB gene fusion demonstrates a common histogenetic origin for dermatofibrosarcoma protuberans and its granular cell variant. Am J Surg Pathol 26 (2002) 932-937
31. Minoletti F., Miozzo M., Pedeutour F., et al. Involvement of chromosomes 17 and 22 in dermatofibrosarcoma protuberans. Genes Chromosomes Cancer 13 (1995) 62-65
32. Hamada M., Hirakawa N., Fukuda T., Furue M., Hori Y., and Tsuneyoshi M. A progression to dermatofibrosarcoma protuberans with a fibrosarcomatous component: a special reference to the chromosomal aberrations. Pathol Res Pract 195 (1999) 451-460
33. Abbott J.J., Oliveira A.M., and Nascimento A.G. The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans. Am J Surg Pathol 30 (2006) 436-443
34. Kiuru-Kuhlefelt S., El-Rifai W., Fanburg-Smith J., Kere J., Miettinen M., and Knuutila S. Concomitant DNA copy number amplification at 17q and 22q in dermatofibrosarcoma protuberans. Cytogenet Cell Genet 92 (2001) 192-195
35. Kaur S., Vauhkonen H., Bohling T., Mertens F., Mandahl N., and Knuutila S. Gene copy number changes in dermatofibrosarcoma protuberans-a fine-resolution study using array comparative genomic hybridization. Cytogenet Genome Res 115 (2006) 283-288